Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:06:07 EDT Wed 09 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:CNSP - CNS PHARMACEUTICALS INC - https://cnsp-rcps.ca
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CNSP - Q0.15.26·6.510.15.76-0.18-3.02.713665.78  5.79  5.7610.588  1.9016:10:05Sep 0115 min RT 2¢

Recent Trades - Last 10 of 66
Time ETExPriceChangeVolume
16:10:05Q5.75-0.191
16:10:04Q5.75-0.191
16:10:04Q5.75-0.191
16:04:04Q5.75-0.191
16:04:04Q5.75-0.191
16:00:10Q5.75-0.191
16:00:10Q5.75-0.191
16:00:10Q5.75-0.191
16:00:00Q5.75-0.199
15:59:48Q5.87-0.071

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-01 09:06U:CNSPNews ReleaseCNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
2026-08-27 09:01U:CNSPNews ReleaseCNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
2026-08-12 08:00U:CNSPNews ReleaseCNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
2026-06-08 09:15U:CNSPNews ReleaseCNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
2026-05-14 08:00U:CNSPNews ReleaseCNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
2026-05-04 07:00U:CNSPNews ReleaseCNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
2026-03-11 08:35U:CNSPNews ReleaseCNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
2026-03-02 08:25U:CNSPNews ReleaseCNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
2026-02-17 08:25U:CNSPNews ReleaseCNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
2026-01-27 09:00U:CNSPNews ReleaseCNS Pharmaceuticals Issues Letter to Shareholders
2025-12-17 07:00U:CNSPNews ReleaseCNS Pharmaceuticals Announces CEO Transition
2025-11-17 08:35U:CNSPNews ReleaseCNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-10 08:45U:CNSPNews ReleaseCNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting